ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W905. A total of 6 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,175 | +4075.0% | 45 | +125.0% | 0.00% | – |
| Q1 2022 | $100 | -75.7% | 20 | -37.5% | 0.00% | – |
| Q4 2021 | $412 | -82.5% | 32 | 0.0% | 0.00% | – |
| Q3 2021 | $2,360 | -69.3% | 32 | +45.5% | 0.00% | – |
| Q2 2021 | $7,680 | +15260.0% | 22 | +120.0% | 0.00% | – |
| Q4 2020 | $50 | -97.8% | 10 | 0.0% | 0.00% | – |
| Q3 2020 | $2,250 | -82.5% | 10 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $12,840 | +366.9% | 10 | +100.0% | 0.00% | – |
| Q1 2020 | $2,750 | -74.7% | 5 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $10,850 | +219.1% | 5 | 0.0% | 0.00% | – |
| Q3 2019 | $3,400 | -55.6% | 5 | -28.6% | 0.00% | -100.0% |
| Q4 2018 | $7,658 | -20.1% | 7 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $9,590 | -44.9% | 7 | -68.2% | 0.00% | -50.0% |
| Q2 2018 | $17,420 | – | 22 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 709,500 | $4,512,000 | 0.01% |
| SIMPLEX TRADING, LLC | 426,100 | $2,709,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 113,600 | $722,000 | 0.00% |